Equitable Trust’s Eastman Chemical EMN Stock Holding History

Equitable Trust’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$256K	Buy	3,359 +66	+2%	+$4.76K	0.01%	427
2025 Q4	$210K	Hold	3,293	–	–	0.01%	429
2025 Q3	$208K	Hold	3,293	–	–	0.01%	429
2025 Q2	$246K	Sell	3,293 -36	-1%	-$2.83K	0.01%	406
2025 Q1	$293K	Hold	3,329	–	–	0.02%	405
2024 Q4	$304K	Buy	3,329 +92	+3%	+$9.43K	0.02%	411
2024 Q3	$362K	Buy	3,237 +15	+0.5%	+$1.5K	0.02%	365
2024 Q2	$316K	Sell	3,222 -628	-16%	-$62.3K	0.02%	374
2024 Q1	$386K	Buy	+3,850	New	+$339K	0.03%	340
2021 Q1	–	Sell	-7,000	Closed	-$702K	–	359
2020 Q4	$702K	Hold	7,000	–	–	0.05%	215
2020 Q3	$547K	Hold	7,000	–	–	0.05%	227
2020 Q2	$487K	Hold	7,000	–	–	0.04%	221
2020 Q1	$326K	Buy	+7,000	New	+$450K	0.04%	246

Other funds holding EMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Equitable Trust's EMN Position: Q1 2026 in Review

Equitable Trust increased its Eastman Chemical (EMN) stake by 2% in Q1 2026, buying an estimated $4.76K and bringing the position to 3,359 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #427.

Equitable Trust first reported a position in EMN in Q1 2020 and has held it in 13 quarters since. The position peaked at $702K in Q4 2020. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

Equitable Trust held 3,359 shares of Eastman Chemical worth $256K as of Q1 2026.
Equitable Trust bought 66 Eastman Chemical shares in Q1 2026, an estimated $4.76K.
Eastman Chemical made up 0.01% of Equitable Trust's portfolio in Q1 2026, its #427 holding.
Equitable Trust first reported a position in Eastman Chemical in Q1 2020 and has held it in 13 quarters since.
Equitable Trust's Eastman Chemical position peaked at $702K in Q4 2020.
634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.